Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1997-04-14
1999-01-12
Davenport, Avis M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
530324, A61K 3800, C07K 500, C07K 700
Patent
active
058589783
ABSTRACT:
Calcitonin gene-related peptide and calcitonin regulate immune cell function and cytokine release and are useful in the treatment of immune cell and cytokine mediated, immune mediated diseases, such as rheumatoid arthritis, treating viral infections, tumors and organ transplants.
REFERENCES:
patent: 5635478 (1997-06-01), Vignery
Nong et al., Journal of Immunology, vol. 143, pp. 45-49, No. 1, Jul. 1, 1989.
Asahina et al.,Proc. Natl. Acad. Sci. USA, vol. 92, pp. 8323-8327, Aug. 1995.
Asahina et al., Journal of Immunology, Inhibition of Induction of Hypersensitivity by CGRP, Dec. 94, pp. 3056-3061.
Palluault et al., "Targeted Expression of Calcitonin Gene Related Peptide to Beta Cells of NOD Mice Prevents Insulin-Dependent Diabetes Mellitus", Yale University, Abs S518, 1995.
Davenport Avis M.
Yale University
LandOfFree
Pharmaceutical compositions containing calcitonin gene-related p does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical compositions containing calcitonin gene-related p, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical compositions containing calcitonin gene-related p will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1516019